Literature DB >> 8244103

Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.

M Esteve-Comas1, M C Núñez, F Fernández-Bañares, A Abad-Lacruz, A Gil, E Cabré, F González-Huix, X Bertrán, M A Gassull.   

Abstract

An abnormal plasma polyunsaturated fatty acid pattern (PUFA) (increased n3 and decreased n6 PUFA) has been reported in active inflammatory bowel disease (IBD). The possibility of a primary defect in the PUFA metabolism in IBD was hypothesised. The aim of this study was to assess plasma PUFA pattern in inactive inflammatory bowel disease and to ascertain whether patients who had had a colectomy and who were suffering from ulcerative colitis have a similar PUFA pattern than those patients with non-active ulcerative colitis and who had not had a colectomy. Plasma fatty acids were analysed by semi-capillary column gas-liquid chromatography in three groups of patients with inactive IBD (24 patients with inactive ulcerative colitis who had not had a colectomy, 15 patients with ulcerative colitis who had had a colectomy, and 27 patients with Crohn's disease). Plasma concentration and percentage of C22:6n3 and unsaturation index were significantly higher in patients with inactive ulcerative colitis without a colectomy and the Crohn's disease group (p < 0.0001) than in controls. Plasma concentration and percentage of C22:6n3 and the unsaturation index remained significantly higher, in both the operated and non-operated ulcerative colitis patients when compared with controls (p < 0.0001). These results suggest that in inactive IBD, an increased PUFA biosynthesis might be the cause of the high values of n3 compounds. These findings although seen in active disease, are more noticeable in remission because of the lack of artefactual factors (malnutrition, steroids, inflammation). In addition, persistence of high values in both groups of ulcerative colitis patients--that is, those who had had a colectomy and those who had not suggests the existence of a primary abnormality in the PUFA metabolism in IBD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244103      PMCID: PMC1374543          DOI: 10.1136/gut.34.10.1370

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  NUTRITIONAL AND METABOLIC INTERRELATIONSHIPS BETWEEN FATTY ACIDS.

Authors:  R T HOLMAN
Journal:  Fed Proc       Date:  1964 Sep-Oct

2.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

Review 3.  Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview.

Authors:  J E Kinsella; B Lokesh; S Broughton; J Whelan
Journal:  Nutrition       Date:  1990 Jan-Feb       Impact factor: 4.008

Review 4.  Prostaglandins and thromboxanes.

Authors:  B Samuelsson; M Goldyne; E Granström; M Hamberg; S Hammarström; C Malmsten
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

5.  Metabolism of 8,11,14-eicosatrienoic acid in human platelets.

Authors:  P Falardeau; M Hamberg; B Samuelsson
Journal:  Biochim Biophys Acta       Date:  1976-08-23

6.  Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.

Authors:  P Needleman; A Raz; M S Minkes; J A Ferrendelli; H Sprecher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Brain lipid modifications induced by essential fatty acid deficiency in growing male and female rats.

Authors:  C Galli; H B White; R Paoletti
Journal:  J Neurochem       Date:  1970-03       Impact factor: 5.372

8.  Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: a multivariate analysis.

Authors:  E Cabré; J L Periago; M D Mingorance; F Fernández-Bañares; A Abad; M Esteve; A Gil; M Lachica; F González-Huix; M A Gassull
Journal:  Am J Clin Nutr       Date:  1992-04       Impact factor: 7.045

9.  Inhibitory effect of docosa-4,7,10,13,16,19-hexaenoic acid upon the oxidative desaturation of linoleic into gamma-linolenic acid and of alpha-linolenic into octadeca-6,9,12,15-tetraenoic acid.

Authors:  R R Brenner; R O Peluffo
Journal:  Biochim Biophys Acta       Date:  1967-02-14

10.  Effect of saturated and unsaturated fatty acids on the desaturation in vitro of palmitic, stearic, oleic, linoleic, and linolenic acids.

Authors:  R R Brenner; R O Peluffo
Journal:  J Biol Chem       Date:  1966-11-25       Impact factor: 5.157

View more
  16 in total

1.  Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease.

Authors:  F Kuroki; M Iida; T Matsumoto; K Aoyagi; K Kanamoto; M Fujishima
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

Review 2.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

3.  Plasma and mucosal fatty acid pattern in colectomized ulcerative colitis patients.

Authors:  M Esteve; E Navarro; J Klaassen; A Abad-Lacruz; F González-Huix; E Cabré; E Ramos; E Condom; F Fernández-Bañares; C Pastor; P Humbert; J Martí-Ragué; M A Gassull
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

4.  Dietary fat intake and inflammatory bowel disease.

Authors:  M A Gassull
Journal:  Curr Gastroenterol Rep       Date:  2001-08

5.  Restorative proctocolectomy for ulcerative colitis: impact on lipid metabolism and adipose tissue and serum fatty acids.

Authors:  Marco Scarpa; Giovanna Romanato; Enzo Manzato; Cesare Ruffolo; Raffaella Marin; Silvia Basato; Sabina Zambon; Teresa Filosa; Silvia Zanoni; Fabio Pilon; Lino Polese; Giacomo C Sturniolo; Davide F D'Amico; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2007-10-23       Impact factor: 3.452

6.  Changes in plasma and colonic mucosa fatty acid profiles in rats with ulcerative colitis induced by trinitrobenzene sulfonic acid.

Authors:  N Nieto; M D Giron; M D Suarez; A Gil
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

7.  Lipid and phospholipid profile after bowel resection for Crohn's disease.

Authors:  Giovanna Romanato; Marco Scarpa; Cesare Ruffolo; Raffaella Marin; Sabina Zambon; Silvia Zanoni; Silvia Basato; Teresa Filosa; Fabio Pilon; Imerio Angriman; Enzo Manzato
Journal:  Int J Colorectal Dis       Date:  2008-07-03       Impact factor: 2.571

Review 8.  Dietary intake of fish, n-3 polyunsaturated fatty acids, and risk of inflammatory bowel disease: a systematic review and meta-analysis of observational studies.

Authors:  Hadis Mozaffari; Elnaz Daneshzad; Bagher Larijani; Nick Bellissimo; Leila Azadbakht
Journal:  Eur J Nutr       Date:  2019-01-24       Impact factor: 5.614

9.  Ileal and colonic fatty acid profiles in patients with active Crohn's disease.

Authors:  S Bühner; E Nagel; J Körber; H Vogelsang; T Linn; R Pichlmayr
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

10.  The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease.

Authors:  J Schwarz; M Vecka; F Stožický; R Pomahačová; B Staňková; E Tvrzická; M Kreslová; R Zahálková; J Sýkora
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.